Revision of the JPMA Code of Practice
May 23, 2025
We are pleased to announce that the revision of the JPMA Code of Practice was approved at the 276th JPMA Assembly held on May 22, 2025.
Please refer to the attached document for details.
- About JPMA
- About Pharmaceuticals
- Information from the Committee
Information from the Committee Top
- Code Compliance Committee
- Pharmaceutical Industrial Policy Committee
- Distribution Improvement Committee
- Drug Evaluation Committee
- Quality & Technology Committee
- Biopharmaceutical Committee
- Regulatory Affairs Committee
- Intellectual Property Committee
- R&D Committee
- International Affairs Committee
- Public Affairs Committee
- Patient Cooperation Committee
- ICH Project
- APAC Project
- Consumer Consultation Review Committee
- Environmental Issue Committee
- Newsletter
- News Room
- The Office of Pharmaceutical Industry Research
- For Patients and the Public (About Pharmaceuticals)
-
Information from the Committee
- Code Compliance Committee
- Pharmaceutical Industrial Policy Committee
- Distribution Improvement Committee
- Drug Evaluation Committee
- Quality & Technology Committee
- Biopharmaceutical Committee
- Regulatory Affairs Committee
- Intellectual Property Committee
- R&D Committee
- International Affairs Committee
- Public Affairs Committee
- Patient Cooperation Committee
- ICH Project
- APAC Project
- Consumer Consultation Review Committee
- Environmental Issue Committee
- About JPMA
- Policies and Activities
-
Voluntary Standards
- Charter of Conduct
- JPMA Code of Practice
- Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
- Transparency Guideline for Relationships between Corporate Activities and Patient Groups
- Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
- Clinical Research
- Basic Philosophy and Action Guidelines on Biodiversity
- Guidelines Concerning Appropriate Competition in Japan Pharmaceutical Manufacturers Association Meetings
- Guidelines for the Promotion of Pharmaceutical Industry in Japan
- News Room
-
The Office of Pharmaceutical Industry Research
- Social Media Policy
- Website Terms of Use